Who is sponsoring NCT05700422?

NCT05700422 is sponsored by University of Pennsylvania.

What condition does NCT05700422 study?

NCT05700422 studies Sjogren's Syndrome, Dry Eye.

What drugs are being tested in NCT05700422?

Interventions: Varenicline Nasal Spray.

What is the status of NCT05700422?

NCT05700422 is currently COMPLETED.

Last reviewed 2024-11-05 · How we verify

Nasal Spray Study in Sjogren's Dry Eye Disease

NCT05700422 PHASE4 COMPLETED Results posted

This study will investigate how well OC-01 (varenicline) nasal spray can treat the signs and symptoms of dry eye disease in those Sjogren's Syndrome. Patients at least 18 years old with moderate-to-severe Sjogren's dry eye disease may be eligible for this study. If you are eligible to participate in the study and you decide to join, there will be 3 study visits over approximately 1 month. You will also self-administer the nasal spray at home every day, 2 times a day during this month.

Details

Lead sponsor	University of Pennsylvania
Phase	PHASE4
Status	COMPLETED
Enrolment	39
Start date	Mon May 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Aug 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Sjogren's Syndrome
Dry Eye

Interventions

Varenicline Nasal Spray

Countries

United States